These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

666 related items for PubMed ID: 31242240

  • 1. Evaluating the potential impact and cost-effectiveness of dapivirine vaginal ring pre-exposure prophylaxis for HIV prevention.
    Reidy M, Gardiner E, Pretorius C, Glaubius R, Torjesen K, Kripke K.
    PLoS One; 2019; 14(6):e0218710. PubMed ID: 31242240
    [Abstract] [Full Text] [Related]

  • 2. Dapivirine vaginal ring for HIV prevention: modelling health outcomes, drug resistance and cost-effectiveness.
    Glaubius R, Ding Y, Penrose KJ, Hood G, Engquist E, Mellors JW, Parikh UM, Abbas UL.
    J Int AIDS Soc; 2019 May; 22(5):e25282. PubMed ID: 31074936
    [Abstract] [Full Text] [Related]

  • 3. Modelling impact and cost-effectiveness of oral pre-exposure prophylaxis in 13 low-resource countries.
    Pretorius C, Schnure M, Dent J, Glaubius R, Mahiane G, Hamilton M, Reidy M, Matse S, Njeuhmeli E, Castor D, Kripke K.
    J Int AIDS Soc; 2020 Feb; 23(2):e25451. PubMed ID: 32112512
    [Abstract] [Full Text] [Related]

  • 4. A Review and Economic Analysis of the Dapivirine Vaginal Ring as HIV Pre-Exposure Prophylaxis for Women, to Inform South African Public-Sector Guidelines.
    Leong TD, Nel J, Jamieson L, Osih R, Dawood H, Subedar H, McCaul M, Johnson LF, Cohen K.
    J Acquir Immune Defic Syndr; 2024 Nov 01; 97(3):261-272. PubMed ID: 39051791
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cost-Effectiveness of HIV Pre-exposure Prophylaxis Among Heterosexual Men in South Africa: A Cost-Utility Modeling Analysis.
    Vogelzang M, Terris-Prestholt F, Vickerman P, Delany-Moretlwe S, Travill D, Quaife M.
    J Acquir Immune Defic Syndr; 2020 Jun 01; 84(2):173-181. PubMed ID: 32141959
    [Abstract] [Full Text] [Related]

  • 7. The impact and cost-effectiveness of combined HIV prevention scenarios among transgender women sex-workers in Lima, Peru: a mathematical modelling study.
    Bórquez A, Guanira JV, Revill P, Caballero P, Silva-Santisteban A, Kelly S, Salazar X, Bracamonte P, Minaya P, Hallett TB, Cáceres CF.
    Lancet Public Health; 2019 Mar 01; 4(3):e127-e136. PubMed ID: 30683587
    [Abstract] [Full Text] [Related]

  • 8. Time to Scale Up Preexposure Prophylaxis Beyond the Highest-Risk Populations? Modeling Insights From High-Risk Women in Sub-Saharan Africa.
    Grant H, Gomez GB, Kripke K, Barnabas RV, Watts C, Medley GF, Mukandavire Z.
    Sex Transm Dis; 2020 Nov 01; 47(11):767-777. PubMed ID: 33044426
    [Abstract] [Full Text] [Related]

  • 9. The impact of self-selection based on HIV risk on the cost-effectiveness of preexposure prophylaxis in South Africa.
    Jamieson L, Gomez GB, Rebe K, Brown B, Subedar H, Jenkins S, Shoko N, Bekker LG, Johnson LF, Meyer-Rath G.
    AIDS; 2020 May 01; 34(6):883-891. PubMed ID: 32004205
    [Abstract] [Full Text] [Related]

  • 10. Cost-effectiveness of Injectable Preexposure Prophylaxis for HIV Prevention in South Africa.
    Glaubius RL, Hood G, Penrose KJ, Parikh UM, Mellors JW, Bendavid E, Abbas UL.
    Clin Infect Dis; 2016 Aug 15; 63(4):539-47. PubMed ID: 27193745
    [Abstract] [Full Text] [Related]

  • 11. Adherence, safety, and choice of the monthly dapivirine vaginal ring or oral emtricitabine plus tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis among African adolescent girls and young women: a randomised, open-label, crossover trial.
    Nair G, Celum C, Szydlo D, Brown ER, Akello CA, Nakalega R, Macdonald P, Milan G, Palanee-Phillips T, Reddy K, Tahuringana E, Muhlanga F, Nakabiito C, Bekker LG, Siziba B, Hillier SL, Baeten JM, Garcia M, Johnson S, McClure T, Levy L, Livant E, Jacobson C, Soto-Torres L, van der Straten A, Hosek S, Rooney JF, Steytler J, Bunge K, Parikh U, Hendrix C, Anderson P, Ngure K, REACH Protocol Team.
    Lancet HIV; 2023 Dec 15; 10(12):e779-e789. PubMed ID: 37898146
    [Abstract] [Full Text] [Related]

  • 12. HIV pre-exposure prophylaxis and early antiretroviral treatment among female sex workers in South Africa: Results from a prospective observational demonstration project.
    Eakle R, Gomez GB, Naicker N, Bothma R, Mbogua J, Cabrera Escobar MA, Saayman E, Moorhouse M, Venter WDF, Rees H, TAPS Demonstration Project Team.
    PLoS Med; 2017 Nov 15; 14(11):e1002444. PubMed ID: 29161256
    [Abstract] [Full Text] [Related]

  • 13. The cost-effectiveness of multi-purpose HIV and pregnancy prevention technologies in South Africa.
    Quaife M, Terris-Prestholt F, Eakle R, Cabrera Escobar MA, Kilbourne-Brook M, Mvundura M, Meyer-Rath G, Delany-Moretlwe S, Vickerman P.
    J Int AIDS Soc; 2018 Mar 15; 21(3):. PubMed ID: 29537654
    [Abstract] [Full Text] [Related]

  • 14. Acceptability of the Dapivirine Vaginal Ring and Daily Oral Pre-exposure Prophylaxis (PrEP) during Pregnancy in Malawi, South Africa, Uganda, and Zimbabwe.
    Young AM, Stoner MCD, Mathebula F, Mohuba R, Baez A, Seyama L, Mutero P, Etima J, Fabiano Z, Fairlie L, Mayo AJ, Balkus JE, Song M, Bunge K, Piper J, Balan IC, van der Straten A, Montgomery ET.
    AIDS Behav; 2024 Nov 15; 28(11):3615-3628. PubMed ID: 39052199
    [Abstract] [Full Text] [Related]

  • 15. Cost and cost-effectiveness analysis of pre-exposure prophylaxis among men who have sex with men in two hospitals in Thailand.
    Suraratdecha C, Stuart RM, Manopaiboon C, Green D, Lertpiriyasuwat C, Wilson DP, Pavaputanon P, Visavakum P, Monkongdee P, Khawcharoenporn T, Tharee P, Kittinunvorakoon C, Martin M.
    J Int AIDS Soc; 2018 Jul 15; 21 Suppl 5(Suppl Suppl 5):e25129. PubMed ID: 30033559
    [Abstract] [Full Text] [Related]

  • 16. Depression Among Pregnant and Breastfeeding Persons Participating in Two Randomized Trials of the Dapivirine Vaginal Ring and Oral Pre-Exposure Prophylaxis (PrEP) in Malawi, South Africa, Uganda, and Zimbabwe.
    Stoner MCD, Mathebula F, Sedze N, Seyama L, Mohuba R, Fabiano Z, Etima J, Young A, Scheckter R, van der Straten A, Piper J, Noguchi L, Montgomery ET, Balán IC.
    AIDS Behav; 2024 Jul 15; 28(7):2264-2275. PubMed ID: 38526641
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and cost-effectiveness of early antiretroviral therapy and partners' pre-exposure prophylaxis among men who have sex with men in Shenyang, China: a prospective cohort and costing study.
    Hu QH, Meyers K, Xu JJ, Chu ZX, Zhang J, Ding HB, Han XX, Jiang YJ, Geng WQ, Shang H.
    BMC Infect Dis; 2019 Jul 25; 19(1):663. PubMed ID: 31345169
    [Abstract] [Full Text] [Related]

  • 18. A Cost-effectiveness Analysis of Preexposure Prophylaxis for the Prevention of HIV Among Los Angeles County Men Who Have Sex With Men.
    Drabo EF, Hay JW, Vardavas R, Wagner ZR, Sood N.
    Clin Infect Dis; 2016 Dec 01; 63(11):1495-1504. PubMed ID: 27558571
    [Abstract] [Full Text] [Related]

  • 19. Cost-effectiveness of easy-access, risk-informed oral pre-exposure prophylaxis in HIV epidemics in sub-Saharan Africa: a modelling study.
    Phillips AN, Bershteyn A, Revill P, Bansi-Matharu L, Kripke K, Boily MC, Martin-Hughes R, Johnson LF, Mukandavire Z, Jamieson L, Meyer-Rath G, Hallett TB, Ten Brink D, Kelly SL, Nichols BE, Bendavid E, Mudimu E, Taramusi I, Smith J, Dalal S, Baggaley R, Crowley S, Terris-Prestholt F, Godfrey-Faussett P, Mukui I, Jahn A, Case KK, Havlir D, Petersen M, Kamya M, Koss CA, Balzer LB, Apollo T, Chidarikire T, Mellors JW, Parikh UM, Godfrey C, Cambiano V, HIV Modelling Consortium.
    Lancet HIV; 2022 May 01; 9(5):e353-e362. PubMed ID: 35489378
    [Abstract] [Full Text] [Related]

  • 20. HIV prevention at drug shops: awareness and attitudes among shop dispensers and young women about oral pre-exposure prophylaxis and the dapivirine ring in Shinyanga, Tanzania.
    Tubert J, Packel L, Hunter LA, Mfaume R, Njau P, Ramadhani AA, Liu JX, McCoy SI.
    AIDS Res Ther; 2021 Apr 26; 18(1):21. PubMed ID: 33902623
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.